ACM Research, Inc (ACMR) is a leading semiconductor equipment & materials business based in the US. It opened the day at $76 after a previous close of $75.92. During the day the price has varied from a low of $70.16 to a high of $76.5. The latest price was $71.37 (25 minute delay). ACM Research is listed on the NASDAQ and employs 361 staff. All prices are listed in US Dollars.
Since the stock market crash in March caused by coronavirus, ACM Research's share price has had significant positive movement.
Its last market close was $72.13, which is 46.32% up on its pre-crash value of $38.72 and 352.23% up on the lowest point reached during the March crash when the shares fell as low as $15.95.
If you had bought $1,000 worth of ACM Research shares at the start of February 2020, those shares would have been worth $738.09 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,030.46.
|52-week range||$15.95 - $113.87|
|50-day moving average||$78.6474|
|200-day moving average||$78.7413|
|Wall St. target price||$125.13|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.674|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-15)||-24.56%|
|1 month (2020-12-23)||2.06%|
|3 months (2020-10-23)||5.00%|
|6 months (2020-07-23)||-18.66%|
|1 year (2020-01-23)||77.27%|
|2 years (2019-01-23)||669.90%|
|3 years (2018-01-23)||1,160.95%|
Valuing ACM Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ACM Research's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ACM Research's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 103x. In other words, ACM Research shares trade at around 103x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
ACM Research's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.9 million (£0.0 million).
The EBITDA is a measure of a ACM Research's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$135.7 million|
|Operating margin TTM||14.68%|
|Gross profit TTM||$50.7 million|
|Return on assets TTM||5.22%|
|Return on equity TTM||10.8%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
There are currently 1.1 million ACM Research shares held short by investors – that's known as ACM Research's "short interest". This figure is 0.4% down from 1.1 million last month.
There are a few different ways that this level of interest in shorting ACM Research shares can be evaluated.
ACM Research's "short interest ratio" (SIR) is the quantity of ACM Research shares currently shorted divided by the average quantity of ACM Research shares traded daily (recently around 219173.67346939). ACM Research's SIR currently stands at 4.9. In other words for every 100,000 ACM Research shares traded daily on the market, roughly 4900 shares are currently held short.
However ACM Research's short interest can also be evaluated against the total number of ACM Research shares, or, against the total number of tradable ACM Research shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ACM Research's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 ACM Research shares in existence, roughly 60 shares are currently held short) or 0.0837% of the tradable shares (for every 100,000 tradable ACM Research shares, roughly 84 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ACM Research.
Find out more about how you can short ACM Research stock.
We're not expecting ACM Research to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, ACM Research's shares have ranged in value from as little as $15.95 up to $113.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ACM Research's is 0.924. This would suggest that ACM Research's shares are less volatile than average (for this exchange).
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase of megasonic waves to deliver megasonic energy to flat and patterned wafer surfaces in a uniform manner on a microscopic level; timely energized bubble oscillation cleaning equipment for two-dimensional and three-dimensional patterned wafers at advanced process nodes; and single-wafer tools for back-end assembly and packaging equipment, as well as electro-chemical plating equipment for advanced metal plating. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was founded in 1998 and is headquartered in Fremont, California.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.